Zealand Pharma A/S (NASDAQ:ZEAL)

22.00
Delayed Data
As of Nov 26
 +0.70 / +3.31%
Today’s Change
21.19
Today|||52-Week Range
40.00
-38.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$999.2M

Company Description

Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark.

Contact Information

Zealand Pharma A/S
Sydmarken 11
Soborg Zealand 2860
P:(458) 877-3600
Investor Relations:

Employees

Shareholders

Other institutional1.26%
Mutual fund holders0.55%
Individual stakeholders--

Top Executives

Emmanuel DulacPresident & Chief Executive Officer
Ivan M. MøllerSenior VP-Technical Development & Operations
Matthew D. DallasChief Financial Officer & Senior Vice President
Adam Sinding SteensbergChief Medical Officer, EVP-Research & Development
Danilo VergeHead-Global Medical Affairs